Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305351
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-03-05
Brief Title:
A Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of K-757 and K-833 in OverweightObese Patients With Type 2 Diabetes
Sponsor:
Kallyope Inc
Organization:
Kallyope Inc
Study Overview
Official Title:
A 42-Day Multiple Dose Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of K-757 And K-833 in OverweightObese Patients With Type 2 Diabetes Mellitus
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multiple dose study to evaluate the safety tolerability PK and PD of K-757 and K-833 when co-administered in overweightobese patients with Type 2 diabetes mellitus T2DM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None